Cargando…
MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
Hypertensive disorder in pregnancy is a major cause of maternal and perinatal mortality worldwide. Women who have had preeclampsia are at three to four times higher risk in later life of developing high blood pressure and heart disease. Soluble Flt-1 (sFlt-1) is elevated in preeclampsia and may rema...
Autores principales: | Sanchez-Aranguren, Lissette Carolina, Rezai, Homira, Ahmad, Shakil, Alzahrani, Faisal A., Sparatore, Anna, Wang, Keqing, Ahmed, Asif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402164/ https://www.ncbi.nlm.nih.gov/pubmed/32660064 http://dx.doi.org/10.3390/antiox9070598 |
Ejemplares similares
-
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment
por: Rezai, Homira, et al.
Publicado: (2020) -
Hydrogen sulfide releasing molecule MZe786 inhibits soluble Flt-1 and prevents preeclampsia in a refined RUPP mouse model
por: Saif, Jaimy, et al.
Publicado: (2020) -
Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells
por: Sanchez-Aranguren, Lissette Carolina, et al.
Publicado: (2020) -
sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023) -
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)